ArticleBreast cancer (Tokyo, Japan)2022

Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3.

Barbara Zellinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.